Orchid Of India, Pfizer Of U.S. Settle Patent Dispute Over Effexor XR
This article was originally published in PharmAsia News
Executive Summary
India's Orchid Chemicals and U.S. drug giant Pfizer agreed to an out-of-court settlement of a patent dispute over the extended-release version of Effexor XR (venlafaxine) antidepressant